Silaras, Concepcion C.
HRN: 26-90-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2025
CEFTAZIDIME 1GM (VIAL)
04/01/2025
04/08/2025
IV
2g
Q8h
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes